# IGC Pharma, Inc.: Form 8-K, filed Dec 29, 2022

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2022-12-29
- Accepted by EDGAR: Dec 29, 2022, 09:19 ET
- Period: 2022-12-24
- Accession: 0001185185-22-001458
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/indiaglob20221228_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/indiaglob20221228_8k.htm

Filed Dec 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001185185-22-001458. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.